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We present the ﬁndings of a large linkage study of bipolar affective disorder (BPAD) that involved genomewide
analysis of 52 families (448 genotyped individuals) of Spanish, Romany, and Bulgarian descent and further ﬁne
mapping of the 1p34-p36, 4q28-q31, and 6q15-q24 regions. An additional sample of 56 German families (280
individuals) was included for this ﬁne-mapping step. The highest nonparametric linkage scores obtained in the ﬁne
mapping were 5.49 for 4q31 and 4.87 for 6q24 in the Romany families and 3.97 for 1p35-p36 in the Spanish
sample. MOD-score (LOD scores maximized over genetic model parameters) analysis provided signiﬁcant evidence
of linkage to 4q31 and at least borderline signiﬁcance for the 1p and 6q regions. On the basis of these results and
previous positive research ﬁndings, 4q31 and 6q24 should now be considered conﬁrmed BPAD susceptibility loci,
and 1p35-p36 is proposed as a new putative locus that requires conﬁrmation in replication studies.
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Bipolar affective disorder (BPAD [MIM 125480]) is a
major psychiatric disorder characterized by episodes of
mania and depression. It affects 0.5%–1.5% of the
world population and constitutes a major public health
problem, with signiﬁcant morbidity and mortality (World
Health Organization 2002). Family, twin, and adoption
studies have provided strong evidence of a major genetic
contribution to the etiology of BPAD (Craddock and
Jones 1999). The pattern of inheritance is complex, sug-
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Table 1
Overview of the Samples Studied in the Genomewide Scan and Fine-Mapping Linkage
Analysis
SAMPLE
NO. OF
FAMILIES
NO. OF
FAMILY
MEMBERS
NO. OF AFFECTED/MEAN NO.
AFFECTED PER FAMILY
ASDI ASDII ASDIII
Spanish 42a 357 103/2.4 144/3.4 209/5
Bulgarian 7a 32 14/2 15/2.1 16/2.3
Romany 3a 59 13/4.3 17/5.7 35/11.7
German 56b 280 92/1.6 101/1.8 117/2.1
All:
Genomewide scan 52 448 130/2.5 176/3.4 260/5
Fine-mapping linkage analysis 108 728 222/2 277/2.6 377/3.5
NOTE.—ASDI includes BPI; ASDII includes BPI, BPII, or SA/BP; ASDIII includes BPI, BPII,
SA/BP, or UPR.
a Determined by genomewide scan and ﬁne-mapping linkage analysis.
b Determined by ﬁne-mapping linkage analysis.
Table 2
Genomewide Scan: Multipoint NPL Analysis
(Nominal ) of the Entire Linkage SampleP ! .05
and Each Subsample
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
gesting the involvement of both multiple genes and
environmental factors. Although linkage analysis of
BPAD has been an unsurprisingly challenging endeavor
(Schulze and McMahon 2003), some genomic regions
have gained consistent support from different studies
and are therefore likely to contain BPAD susceptibility
loci (Badner and Gershon 2002; Segurado et al. 2003).
Here, we present new data from a genomewide link-
age analysis and subsequent ﬁne-mapping analysis con-
ducted in one of the largest collections of BPAD-affected
families to date. The genome scan was performed on 52
families (Spanish, Bulgarian, and Romany, the latter re-
cruited in Bulgaria) consisting of 448 subjects, of whom
260 were affected (according to the broad phenotype def-
inition, ASDIII [described below]). An additional sample
of 56 German families with 280 members (117 affected)
for which a previously completed genome scan produced
overlapping results (Cichon et al. 2001) was included
for the ﬁne-mapping stage. The characteristics of these
families are summarized in table 1. Informed consent
was obtained from all participating subjects. The study
complies with all ethical guidelines of the institutions
involved.
Phenotype evaluation (Fangerau et al. 2004) was based
on DSM-IV criteria (American Psychiatric Association
1994). The inclusion criteria for BPAD-affected families
were the presence of (1) a proband with bipolar I dis-
order (BPI) and (2) a secondary affected siblingwith either
BPI, bipolar II (BPII), schizoaffective disorder bipolar
type (SA/BP), or unipolar recurrent depression (UPR). All
individuals were interviewed by an experienced psychi-
atrist. The Schedule for Affective Disorders and Schizo-
phrenia–Lifetime Version (SADS-L) (Endicott and Spit-
zer 1978) was used for the German and Spanish families.
The Schedules for Clinical Assessment in Neuropsychi-
atry (Wing et al. 1990) was used for the Bulgarian and
Romany families. The affected status deﬁnitions (ASD)
used in the linkage analysis were as follows: ASDI (nar-
row) includes individuals with BPI only, with all other
psychiatric diagnoses coded as “unknown”; ASDII (me-
dium) includes all individuals who received a diagnosis
of BPI, BPII, or SA/BP; and ASDIII (broad) also includes
individuals with UPR.
The genome scan was conducted at the GeneMapping
Center in Berlin, with use of procedures described by
Lee et al. (2000). The 448 DNA samples were genotyped
for 435 STRs, with an average intermarker distance of
8.3 cM (range 0–25.4 cM) (deCODE Genetics). An av-
erage heterozygosity of 0.77 was observed.
Nonparametric linkage (NPL) analysis of the genome
scan data was performed using the current version of
GENEHUNTER, version 2.1 release 5 (Kruglyak et al.
1996; Kruglyak and Lander 1998; Markianos et al.
2001). Marker-allele frequencies were estimated for all
samples by a maximum-likelihood procedure with use
of the program MENDEL (version 5.5). Identical-by-
descent allele sharing among all affected family members
was calculated for the narrow, medium, and broad af-
fection–status deﬁnition with use of the GENEHUNTER
score function SALL.
The genomewide linkage analysis (see detailed results
in table 2 and ﬁgs. 1–4) produced nominal evidence
of linkage ( ) to 17 chromosomal regions: 1p34-P ! .05
p36, 2p16-p25, 3p25, 4p16, 4q25-q31, 4q35, 6q21-
q24, 10p13, 11p15, 11p13-q13, 12p11-p13, 13q12-
q13, 15q14, 15q26, 17p12, 19p12-p13, and Xq23-q25.
Strongest support was obtained for the 1p34-p36, 4q25-
q31, and 6q21-q24 regions.
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Figure 1 Genomewide scan: multipoint NPL analysis of ASDI,
ASDII, and ASDIII, across all chromosomes in the entire linkage sample.
Figure 2 Genomewide scan: multipoint NPL analysis of ASDI,
ASDII, and ASDIII, across all chromosomes in the Spanish linkage
sample.
On chromosome 1p34-p36, the maximum NPL score
for the combined sample was 3.34 at 38.9 cM under
the broad phenotype (ASDIII) deﬁnition. Nominally sig-
niﬁcant results were obtained in the Spanish (ASDIII:
at 37.78 cM) and the Romany (ASDI:NPLp 3.36
at 27.6 cM) samples. For 4q25-q31, for theNPLp 2.28
entire sample, an NPL score of 2.89 was found at 138.7
cM for ASDII. Nominally signiﬁcant results were ob-
tained for the Spanish (ASDII: at 136.5 cM)NPLp 2.75
and the Romany (ASDII: at 150.8 cM) fam-NPLp 1.94
ilies. In the 6q21-q24 region, the maximum NPL score
for the combined sample was 2.66 at 134.2 cM for AS-
DIII. The breakdown showed nominally signiﬁcant re-
sults in all subsamples: Romany (ASDIII: NPLp 3.65
at 145.0 cM), Spanish (ASDII: at 125.4NPLp 2.25
cM), and Bulgarian (ASDIII: at 134.2 cM).NPLp 1.89
Fine-mapping analysis of these three regions was per-
formed for those family subsets demonstrating the stron-
gest evidence of linkage: Spanish, Romany, and Bulgar-
ian for chromosome 1p; Romany, Bulgarian, andGerman
(Cichon et al. 2001) for chromosome 4q; and Spanish,
Romany, Bulgarian, and German for chromosome 6q.
The genotyping was performed by deCODE Genetics,
with use of procedures described elsewhere (Bjo¨rnsson
et al. 2003). A total of 91 additional STR markers were
analyzed, distributed by regions as follows: chromosome
1p34-p36, interval D1S2672–D1S2741 (27.8–86.1 cM),
27 STRs, average intermarker distance 2.1 cM; chro-
mosome 4q28-q31, interval D4S1615–D4S2982 (129.7
cM–157.5 cM), 13 STRs, average intermarker distance
2.1 cM; chromosome 6q15-q24, interval D6S1570–
D6S1633 (101.5–170.2 cM), 51 STRs, average inter-
marker distance 1.3 cM. To determine the inferential
validity of the maximum NPL scores that were obtained
using the ﬁne-mapping data and the program GENE-
HUNTER, we performed systematic simulations under
the null hypothesis of no linkage. Because of insufﬁcient
computation time, we generated either 500 or 1,000
replicates, depending on the magnitude of the observed
NPL score. The replicates were generated using MER-
LIN, version 0.10.2 (Abecasis et al. 2002). Each replicate
was generated under the assumption of random segre-
gation, with use of identical pedigree structure, affection
status, marker spacing, allele frequencies, and patterns
of the missing data in the real data set. Each replicate
was analyzed, using MERLIN, in the same way as was
the original data set, with computation of theZmean score,
which is equivalent to theNPL score inGENEHUNTER.
The empirical P value was calculated as the portion of
all replicates showing an NPL score equal to or higher
than the one observed in the real data set.
In parametric linkage analysis, the trait model must
be speciﬁed prior to analysis. This is a disadvantage when
the true disease model parameters are unknown, since
the power to detect linkage decreases when the speci-
ﬁed model is not sufﬁciently close to the true mode of
inheritance (Clerget-Darpoux et al. 1986). Therefore, in
addition to the NPL analyses, we performed multipoint
LOD scores maximized over genetic model parameters
(MOD)–score analyses in the ﬁne-mapping linkage study,
and we maximized parametric LOD scores with respect
to the disease-model parameters. We used the new pro-
gram GENEHUNTER-MODSCORE (Strauch 2003),
which calculates MOD scores by automatically varying
the disease-allele frequency and three penetrances. The
program is a further development of GENEHUNTER-
IMPRINTING (Strauch et al. 2000), which is based on
the original GENEHUNTER, version 2.1 (Kruglyak et
al. 1996; Kruglyak and Lander 1998; Markianos et
al. 2001). We used the “modcalc single” option, under
which GENEHUNTER-MODSCORE performs a sepa-
rate maximization for each genetic position assumed for
the putative disease locus. This procedure yields the
MOD score in conjunction with the best-ﬁtting pene-
trance and disease-allele frequency at each genetic po-
sition of a prespeciﬁed grid. The parameters can be con-
sidered an effect estimate for the particular locus. Given
the nature of our large data set and its many extended
pedigrees, a further reduction in the number of chromo-
somal regions to be analyzed was necessary for reasons
of acceptable computation time. The intervals analyzed
in this manner were D1S2672–D1S1598 (27.82–65.0
cM) on 1p; D4S1527–D4S2982 (134.67–157.54 cM) on
4q, andD6S270–D6S1633 (138.78–170.24 cM) on chro-
mosome 6q. For all regions and disease deﬁnitions, the
analyses were run for the pooled set of populations.
Detailed results of ﬁne mapping for both the combined
sample and for the subsamples (Spanish, Romany, Bul-
garian, and German) are presented in table 3.
On chromosome 1p34-p36, we genotyped 27 addi-
tional STR markers, which covered a region of 58.3 cM.
In the combined sample, an NPL score of 3.69 (empirical
) was obtained at 45.9 cM for ASDIII. The bestPp .003
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Figure 3 Genomewide scan: multipoint NPL analysis of ASDI,
ASDII, and ASDIII, across all chromosomes in the Romany linkage
sample.
Figure 4 Genomewide scan: multipoint NPL analysis of ASDI,
ASDII, and ASDIII, across all chromosomes in the Bulgarian linkage
sample.
subsample score was observed in the Spanish families
(ASDIII: at 45.9 cM; empirical )NPLp 3.97 Pp .005
(see ﬁg. 5). The highest MOD score value, 3.40, was
obtained in the combined sample at 45.9 cM for ASDIII
and a near-dominant mode of inheritance (ﬁg. 6). The
data suggest that the susceptibility allele at this locus
has a high frequency (16%) and incomplete penetrance
(53%). The results for ASDI and ASDII were weaker,
with MOD scores of 2.02 and of 1.36, respectively (ﬁg.
6). The linkage region deﬁned by the NPL and MOD-
score analyses is well circumscribed and covers !5 cM
between markers D1S478 and D1S493 on chromosome
1p35-p36. This region has not been proposed previously
as a BPAD locus. However, review of published data
shows that Curtis et al. (2003) observed a LOD score
of 3.10 at D1S432 in one large pedigree with BPAD.
This marker is not, however, listed by the deCODE Ge-
netics map. According to National Center for Biotech-
nology Information (NCBI) Build 35, D1S432 is located
!9 Mb centromeric of the linkage region implicated
by our study. In addition, ∼23 cM more telomeric, at
marker D1S1597 (23.2 cM), Zubenko et al. (2003) ob-
tained a multipoint LOD score of 3.60 in a sample of
81 families with UPR. The fact that the most signiﬁcant
P value in our study was obtained with use of a phe-
notype deﬁnition that includes UPR may suggest the ex-
istence of a susceptibility locus on chromosome 1p35-
p36 that contributes to a broad spectrum of affective
disorders. According to the University of California–
Santa Cruz (UCSC) RefSeq Genes track (UCSC Genome
Bioinformatics), which assembles all known protein-cod-
ing genes taken from the NCBI mRNA reference se-
quences collection (RefSeq), the genomic interval on
chromosome 1p identiﬁed by our ﬁne-mapping analysis
contains 129 genes.
On chromosome 4q28-q31, we analyzed 13 addi-
tional STR markers between D4S1615 (129.7 cM) and
D4S2982 (157.5 cM). In the entire ﬁne-mapping sample,
we obtained evidence of linkage at 151.1 cM, with an
NPL score of 3.18 (empirical ) for ASDII (tablePp .004
3 and ﬁg. 7). The strongest evidence was produced by
the Romany subsample (ASDIII: at 148.4NPLp 5.49
cM; empirical ). Also, the German subsam-Pp .015
ple contributed to the chromosome 4 ﬁnding (ASDII:
at 151.1 cM; empirical ). In theNPLp 2.58 Pp .012
MOD-score analysis of the combined sample—including
the Romany, German, and Bulgarian families—a MOD
score of 4.24 was obtained at 147.2 cM for ASDII, with
a disease-allele frequency of 4.5% and a near-additive
mode of inheritance (ﬁg. 8). Application of the two other
phenotype deﬁnitions supported this region, with aMOD
score of 3.22 at 147.6 cM for ASDI and of 2.76 for
ASDIII (ﬁg. 8). Our ﬁndings conﬁrm the ﬁndings of ge-
nomewide analyses of other investigators. Using a dom-
inant model of inheritance and a broad diagnostic def-
inition, Ekholm et al. (2003) observed a 3-point LOD
score of 3.60 at 152 cM (at marker D4S1629) in a sam-
ple of 41 BPAD-affected families from an isolated Finn-
ish population. In another genomewide scan of 65 Ameri-
can families of European descent with BPAD, an NPL
of 2.80 and a LOD score of 1.9 were reported, again at
152 cM (marker D4S1629) under a broad phenotype
model (McInnis et al. 2003). A genomewide study of 40
pedigrees with BPAD from the United States and Israel
obtained a 2-point LOD score of 3.16 under a domi-
nant model and broad phenotype deﬁnition, with a maxi-
mum at 140 cM (marker D4S1625) (Liu et al. 2003).
The peak identiﬁed in our ﬁne-mapping NPL andMOD-
score analysis spans ∼10 cM and is situated precisely
in the D4S1625–D4S1629 interval supported by the
above-mentioned genomewide analyses. The UCSC Ref-
Seq Genes track (UCSC Genome Bioinformatics) lists 58
protein-coding genes as present in this genomic linkage
interval on chromosome 4q.
Fine mapping of the 6q15-q24 region, ﬂanked by
D6S1570 (101.5 cM) and D6S1633 (170.2 cM), was
performed with 51 additional STRs. This large region
is of particular interest, since several previous studies
have reported “suggestive” and “signiﬁcant” evidence of
linkage to BPAD. Rather than narrowing the region, the
ﬁne-mapping analysis led to the identiﬁcation of three
well-deﬁned positive areas in each subsample, all of which
have been reported elsewhere for BPAD—namely, 6q16,
6q23, and 6q24 (see ﬁg. 9).
Evidence supporting 6q16 was obtained mainly from
the German subsample, with an NPL score of 2.55 (em-
pirical ) at 112.0 cM for ASDII (table 3). Al-Pp .052
though, our results for 6q16 are not strong in terms of
empirical P values, involvement of this region is sup-
ported by ﬁndings from independent linkage studies. The
large National Institute of Mental Health study, which
included a sample of 250 families, reported a LOD score
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Figure 5 Fine-mapping linkage analysis: chromosomal 1p34-p36
multipoint NPL results in the ﬁne-mapping sample and in the Spanish,
Romany, and Bulgarian subsamples of ASDI, ASDII, and ASDIII. The
legend is available in its entirety in the online edition of The American
Journal of Human Genetics.
Table 3
Fine-Mapping Linkage Analysis: Multipoint NPL Analysis in the Fine-Mapping Linkage
Sample (108 Families) and Each Subsample
CHROMOSOME REGION
AND SAMPLE
POSITIONa
(cM)
NPL (EMPIRICAL Pb)
ASDI ASDII ASDIII
1p35-p36:
Fine-mapping sample 45.97 1.93 (.128) 2.65 (.020) 3.69 (.003)c
Spanish subsample 45.97 1.44 (.294) 2.06 (.116) 3.97 (.005)c
Romany subsample 45.97 3.21 (.034) 2.70 (.064) 1.78 (.184)
Bulgarian subsample 45.97 1.26 (.418) 1.26 (.416) …
4q31:
Fine-mapping sample 151.16 2.85 (.010) 3.18 (.004)c 2.36 (.016)
Romany subsample 148.44 3.52 (.014) 3.34 (.016) 5.49 (.015)c
German subsample 151.16 2.15 (.038) 2.58 (.012) 1.61 (.244)
Bulgarian subsample 151.16 1.29 (.258) 1.28 (.244) …
6q16:
Fine-mapping sample 112.06 … 1.42 (.358) 1.24 (.468)
German subsample 112.06 2.42 (.058) 2.55 (.052) 2.15 (.104)
6q23:
Fine-mapping sample 135.15 1.75 (.246) 2.85 (.022) 2.59 (.054)
Bulgarian subsample 136.08 2.69 (.026) 2.69 (.026) 2.42 (.044)
Spanish subsample 135.15 … 2.08 (.150) …
6q24:
Fine-mapping sample 147.68 2.27 (.096) 3.18 (.008) 2.53 (.060)
Romany subsample: peak I 147.75 2.99 (.058) 3.21 (.040) 3.46 (.071)c
Romany subsample: peak II 152.00 2.52 (.096) 2.69 (.062) 4.87 (.044)c
German subsample 147.75 1.23 (.470) 1.76 (.230) …
Bulgarian subsample 147.68 1.43 (.430) 1.43 (.444) 1.85 (.044)
NOTE.—ASDI includes BPI; ASDII includes BPI, BPII, or SA/BP; ASDIII includes BPI,
BPII, SA/BP, or UPR.
a Determined from the deCODE Genetics sex-averaged map.
b Empirical P value based on 500 simulations unless otherwise noted.
c Empirical P values are based on 1,000 simulations.
of 2.26 at D6S1021 (107 cM), with use of a broad
disease deﬁnition (Dick et al. 2003; Schulze et al. 2004).
At the same marker, Ewald et al. (2002) found a LOD
score of 2.59 in two multiplex BPAD-affected families
from Denmark with a narrow phenotype deﬁnition, and
Pato et al. (2004) observed an NPL score of 2.59 in 16
Portuguese BPAD-affected families.
We also obtained evidence of linkage to 6q23 (full
ﬁne-mapping sample for ASDII: at 135.1NPLp 2.85
cM; empirical [table 3]), a region that was im-Pp .022
plicated in the Danish BPAD study (Ewald et al. 2002),
with a 2-point LOD score of 2.49 at D6S1009 (139 cM)
with a narrow disease deﬁnition. At the same marker,
Rice et al. (1997) found a 2-point LOD score of 2.08 in
97 American families of European descent. In the latter
study, all markers on 6q between 112 cM and 155 cM
yielded positive LOD scores for a broad affected-status
model. Furthermore, this region was implicated by the
genomewide study of Middleton et al. (2004), in which
they investigated 25 multiplex BPAD-affected families of
Portuguese origin, using the GeneChip HumanMapping
10K Array (HMA10K). They observed an NPL score of
4.20 at 125.8 Mb, which is located ∼6 Mb centromeric
of our strongest linkage ﬁnding within this chromosomal
region.
The third linkage region, 6q24, was supported by the
combined sample, which produced an NPL of 3.18 (em-
pirical ) at 147.68 cM for ASDII. The RomanyPp .008
subsample produced the second-highest NPL score ob-
served in our study (ASDIII: at 152.0 cM;NPLp 4.87
empirical ). Given computational constraintsPp .044
and because the 6q24 results were the best ﬁnding in
this chromosomal region, MOD-score analysis was re-
stricted to this particular locus only. In the combined
sample, this analysis identiﬁed two peaks, at 146.1 and
152.5 cM, with MOD scores 3.59 and 3.10 for ASDIII
(ﬁg. 10). For both peaks, the best genetic model was
nearly additive, with low disease-allele frequencies and
low penetrance. Using the medium and narrow pheno-
type deﬁnitions, we obtained MOD scores of 3.46 at
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Figure 6 Plot of the MOD score for chromosome 1p35-p36, with a separate maximization over trait-model parameters for each genetic
position assumed for the trait locus. ASDI (red) position of the maximum MOD score: 52.34 cM; penetrances {0.00; 0.49; 0.49}; disease-allele
frequency 0.050. ASDII (green) position of the maximum MOD score: 52.63 cM; penetrances {0.00; 0.50; 0.50}; disease-allele frequency 0.040.
ASDIII (blue) position of the maximum MOD score: 45.95 cM; penetrances {0.00; 0.53; 0.53}; disease-allele frequency 0.160. MOD scores
are determined from the deCODE Genetics sex-averaged map. The penetrance of the disease models is obtained by MOD-score analysis and
given in order {f/; fm/; fm/m}. A plus sign () indicates the wild-type allele; “m” indicates the mutant allele.
Figure 7 Fine-mapping linkage analysis: chromosomal 4q28-
4q31 multipoint NPL results in the ﬁne-mapping sample and in the
German, Romany, and Bulgarian subsamples of ASDI, ASDII, and
ASDIII. The legend is available in its entirety in the online edition of
The American Journal of Human Genetics.
145.2 cM (for ASDII) and of 3.32 at 147.6 cM (for
ASDI) (ﬁg. 10). Although previous support for this re-
gion has been modest (Rice et al. 1997; see above),
strong evidence of a 6q24 BPAD susceptibility locus was
provided recently by a genomewide linkage study of an
isolated population in northern Sweden (Venken et al.
2005). The study identiﬁed a 29-cM region on 6q (133–
162 cM), with a multipoint LOD score of 2.48. Follow-
up ﬁne mapping analysis, under a recessive, affected-
only model, led to a 3-cM candidate region (144–147
cM) and a multipoint LOD score of 3.25 at 146 cM,
which matches the peak identiﬁed by our MOD-score
analysis for the narrow and medium phenotype deﬁni-
tions (ﬁg. 10). Collectively, the data provide strong sup-
port for the existence of a BPAD susceptibility locus on
6q24, a chromosomal region with relatively sparse gene
entries. According to the RefSeq Genes track (UCSCGe-
nome Bioinformatics), the genomic interval analyzed by
our MOD-score analysis contains 32 genes.
The 108 affected families included in this study orig-
inate from four different European populations and rep-
resent one of the largest BPAD samples investigated to
date. The fact that the extended Romany families pro-
duced the highest NPL scores, together with the ﬁndings
of previous genome scans for BPAD in isolated popu-
lations, emphasizes the potential of such populations to
facilitate gene identiﬁcation in complex disorders. Al-
though the number of susceptibility loci for BPAD in
these isolated populations may not be substantially dif-
ferent from those of other populations, as suggested by
our results and those of other studies (Fallin et al. 2004;
Venken et al. 2005), isolated populations still offer ad-
vantages for genetic studies because of their limited di-
versity and presumed strong founder effects.
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Figure 8 Plot of the MOD score for chromosome 4q31, with a separate maximization over trait-model parameters for each genetic
position assumed for the trait locus. ASDI (red) position of the maximum MOD score: 147.64 cM; penetrances {0.00; 0.30; 0.92}; disease-
allele frequency 0.025. ASDII (green) position of the maximum MOD score: 147.23 cM; penetrances {0.00; 0.33; 0.99}; disease-allele frequency
0.045. ASDIII (blue) position of the maximum MOD score: 148.44 cM; penetrances {0.00; 0.49; 0.96}; disease-allele frequency 0.040. MOD
scores are determined from the deCODE Genetics sex-averaged map. The penetrance of the disease models is obtained by MOD-score analysis
and given in order {f/; fm/; fm/m}. A plus sign () indicates the wild-type allele; “m” indicates the mutant allele.
Figure 9 Fine-mapping linkage analysis: chromosomal 6q15-
q24 multipoint NPL results in the ﬁne-mapping sample and in the
German, Romany, Spanish, and Bulgarian subsamples of ASDI, ASDII,
and ASDIII. The legend is available in its entirety in the online edition
of The American Journal of Human Genetics.
Our genomewide scan identiﬁed several genomic re-
gions likely to contain BPAD-susceptibility loci, some of
which overlap with and provide further support for pre-
vious ﬁndings. Our subsequent ﬁne-mapping linkage an-
alysis led to substantially better results in all of the in-
vestigated regions and shaped the linkage peaks (e.g., in
the Romany subsample, the NPL scores increased from
2.28 to 3.21 for chromosome 1p, from 1.65 to 5.49 for
4q, and from 3.65 to 4.87 for 6q, whereas, in the Spanish
subsample, the NPL scores for 1p increased from 3.36
to 3.97). In addition, we applied parametric multipoint
MOD-score analysis to the ﬁne-mapping linkage data.
Since the power to detect linkage is reduced when the
trait model speciﬁed for a parametric (LOD score) anal-
ysis is not close to the true underlying model (Clerget-
Darpoux et al. 1986), MOD-score analysis is a prom-
ising strategy for analysis of linkage data for complex
traits. Although applied only to those chromosomal
regions identiﬁed by the preceding NPL analysis, this
approach is clearly explorative and thus does not allow
stringent control of type I error. In principle, P values
of MOD scores can be obtained by performing simu-
lations for the investigated data set under the null hy-
pothesis of no linkage. For our BPAD-affected family
sample, a substantial amount for computation time is
already required for the MOD-score analysis of the orig-
inal data set. Analysis of many replicates for each of the
loci identiﬁed here would therefore not be feasible; we
relied instead on the criteria of Weeks et al. (1990) and
Hodge et al. (1997). By performing simulations, they
have found that, for MOD scores, a critical LOD score
of 3 should be adjusted by a value in the range of 0.3–
1.0 to maintain a comparable type I error, with a con-
servative upper boundary. When applied to the results
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Figure 10 Plot of the MOD score for chromosome 6q24, with a separate maximization over trait-model parameters for each genetic
position assumed for the trait locus. ASDI (red) position of the maximum MOD score: 147.68 cM; penetrances {0.00; 0.50; 0.50}; disease-
allele frequency 0.005. ASDII (green) position of the maximum MOD score: 145.18 cM; penetrances {0.00; 0.52; 0.52}; disease-allele frequency
0.010. ASDIII (blue) position of the maximum MOD score: 146.13 cM; penetrances {0.00; 0.11; 0.26}; disease-allele frequency 0.005. MOD
scores are determined from the deCODE Genetics sex-averaged map. The penetrance of the disease models is obtained by MOD-score analysis
and given in order {f/; fm/; fm/m}. A plus sign () indicates the wild-type allele; “m” indicates the mutant allele.
of our study, that means that we have obtained “sig-
niﬁcant” evidence of a susceptibility locus in the 4q re-
gion and at least “borderline signiﬁcance” for the regions
on chromosomes 1p and 6q.
On the basis of our ﬁndings in two independent family
samples, we propose the 1p35-p36 locus as a new sus-
ceptibility locus for BPAD. Chromosomal regions 4q31
and 6q24 have already been implicated in previous stud-
ies and, in the light of our results, should now be con-
sidered to be true-positive ﬁndings. The present study
is the ﬁrst application of the newly developed GENE-
HUNTER-MODSCORE program to BPAD, which al-
lows a more precise deﬁnition of linkage peaks and es-
timation of disease inheritance parameters. The different
pattern of linkage ﬁndings observed in the comparison
of the individual subsamples in our study is not sur-
prising. This phenomenon is to be expected with a ge-
netically complex disorder (Suarez et al. 1994), since
factors such as the structure and size of the family sam-
ples, incomplete penetrance, and locus heterogeneity in-
ﬂuence the linkage results and may lead to interstudy
differences (Terwilliger et al. 1997). Thus, our results re-
ﬂect and support the opinion that BPAD is caused by
multiple genes, with presumed genetic heterogeneity and
with different combinations of predisposing genes seg-
regating in different families and populations. Some of
these were found within those regions identiﬁed by our
extensive ﬁne-mapping NPL and MOD-score analyses.
The next step will be systematic linkage disequilibrium
mapping in these identiﬁed regions, followed by the ap-
plication of positional cloning methods.
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